ライフサイエンスコーパス: precancerous lesion

1 t progression of ductal carcinoma in situ, a precancerous lesion.

2 essed in esophageal adenocarcinoma (EAC) and precancerous lesions.

3 epithelial cells and induce both benign and precancerous lesions.

4 has not been done to determine their role as precancerous lesions.

5 h the presence or absence of skin cancer and precancerous lesions.

6 al SCC and the effectiveness of treatment of precancerous lesions.

7 elerate the development of H. pylori-induced precancerous lesions.

8 al predictor of the size and multiplicity of precancerous lesions.

9 nd rapid targeted therapy of colon cancer or precancerous lesions.

10 V testing for the identification of cervical precancerous lesions.

11 ays containing esophageal adenocarcinoma and precancerous lesions.

12 o enhance the detection of early cancers and precancerous lesions.

13 nd may forecast a similar effect on cervical precancerous lesions.

14 associated with an increased risk of gastric precancerous lesions.

15 ntiation following tissue damage, leading to precancerous lesions.

16 ith men (MSM) without history of anal cancer/precancerous lesions.

17 vated (phosphorylated at T68) in cancers and precancerous lesions.

18 the maintenance of cervical cancers and most precancerous lesions.

19 adenocarcinoma, squamous cell carcinoma and precancerous lesions.

20 r utility for detection of melanoma onset in precancerous lesions.

21 cervical HPV 16/18 infections and associated precancerous lesions.

22 ancerous tissues including tissue containing precancerous lesions.

23 o accelerate the development of hyperplastic precancerous lesions.

24 on, anogenital warts, and cervical cancer or precancerous lesions.

25 omozygous deletions in many cancer cells and precancerous lesions.

26 proliferation can be an initiating event for precancerous lesions.

27 characteristics similar to those reported in precancerous lesions.

28 f sustained protection against infection and precancerous lesions.

29 ich is universally accelerated in cancer and precancerous lesions.

30 ectiveness of screening for and treatment of precancerous lesions.

31 ated cervical cytological abnormalities, and precancerous lesions.

32 For precancerous lesions, 9 studies were included that analy

33 olorectal cancer and 757 (7.6%) had advanced precancerous lesions (advanced adenomas or sessile serra

34 ls of selected bacterial species and gastric precancerous lesions, although an elevated but non-signi

35 dontal disease-related pathogens and gastric precancerous lesions among those with higher versus lowe

36 to determine whether KRAS(G12D) would block precancerous lesion and tumor formation in follicles of

37 esophagus, stomach, and colon in people with precancerous lesions and a high risk of developing these

38 nd calibrated it to US epidemiologic data on precancerous lesions and cancer.

39 ubsequent HPV acquisition and progression to precancerous lesions and cancers.

40 CA9 expression in esophageal cancers and in precancerous lesions and explored the association of CA9

41 prostate gland susceptibility to adult-onset precancerous lesions and hormonal carcinogenesis.

42 tion of mutations that are seen within later precancerous lesions and in established malignancy can a

43 ion of Fhit in a small proportion of colonic precancerous lesions and in increased proportions of pri

44 mined the expression of Claudin-2 in EAC and precancerous lesions and its association with VDR and TG

45 nd sensitive for the detection of high-grade precancerous lesions and may be used in primary cervical

46 iency leads to persistent DNA damage in both precancerous lesions and primary tumors.

47 l of cutaneous carcinogenesis that manifests precancerous lesions and SCCs resembling human disease.

48 iminate with a very high performance between precancerous lesions and T1a carcinoma (sensitivity, 100

49 is significantly affected in the presence of precancerous lesions and T1a carcinoma.

50 between periodontal disease and the risk for precancerous lesions and tumors generating a hypothesis

51 rogression, including delayed development of precancerous lesions, and decreased tumor growth and met

52 infection for high-risk types, prevalence of precancerous lesions, and incidence of cancer.

53 ing of mutational signatures in human cells, precancerous lesions, and primary or metastatic tumors a

54 s were employed: 1) tumor (non-specific); 2) precancerous lesions; and 3) any oral soft tissue lesion

55 Most squamous cell anal cancers and precancerous lesions are attributed to human papillomavi

56 n in 170 cases of esophageal cancer (EC) and precancerous lesions, as well as 20 cases of EC series s

57 ta-carotene has established efficacy in oral precancerous lesions but has no effect or slightly worse

58 integrity and serves as a cancer barrier in precancerous lesions but paradoxically may promote cance

59 which developmental chemical exposure causes precancerous lesions by altering cell fate.

60 cedure to discriminate between malignant and precancerous lesions by measuring the characteristics of

61 reported the underrepresentation of cervical precancerous lesions caused by human papillomavirus (HPV

62 nd who do not have a history of a high-grade precancerous lesion (cervical intraepithelial neoplasia

63 the pancreatic phenotype evolved to resemble precancerous lesions, demonstrating that loss of Lkb1 wa

64 ect of stomach function that is disrupted in precancerous lesions (e.g. metaplasias, chronic atrophy)

65 ost human trials have been conducted against precancerous lesions for SCC.

66 lastic aberrant crypt foci (ACF), a putative precancerous lesion found in the colon, exhibiting a ser

67 ent mechanisms of neoplastic control prevent precancerous lesions from becoming fully malignant, iden

68 phagitis in this patient were similar to the precancerous lesions from high-risk areas for esophageal

69 yclin E in esophageal adenocarcinoma and its precancerous lesion have not been well studied.

70 minimally deleted regions and their role in precancerous lesions have not been well characterized.

71 can lead to colon cancer that is preceded by precancerous lesions having submucosal inflammation and

72 tivated in some actinic keratoses, the major precancerous lesion in human skin.

73 ed oral pathogens is associated with gastric precancerous lesions in a cross-sectional study.

74 Comparison of precancerous lesions in donor woodchucks versus recipien

75 nogenesis and has been shown to regress oral precancerous lesions in humans.

76 Here, we show that VHL inactivation in precancerous lesions in kidneys from patients with VHL d

77 ertain, despite the diagnosis and removal of precancerous lesions in many persons who undergo screeni

78 Tgfbr1 signaling promotes the development of precancerous lesions in mice.

79 epithelia, LSS imaging can be used to detect precancerous lesions in optically accessible organs.

80 liver toxicity and an increased incidence of precancerous lesions in the colon of HZ mice.

81 o reveal that ATM is activated in pancreatic precancerous lesions in the context of DNA damage and ce

82 e acetate promotes regression of cancers and precancerous lesions in the female lower reproductive tr

83 ompare the incidence, frequency, and size of precancerous lesions in the pancreas.

84 E7 in maintaining HPV-associated tumors and precancerous lesions in vivo, we generated Bi-L E7 trans

85 V vaccine (qHPV) reduces risk of anal cancer/precancerous lesions in young men who have sex with men

86 n aberrant expression of MUC4 is reported in precancerous lesions, indicating its early involvement i

87 areas for esophageal squamous cancer and the precancerous lesions induced in rats by N-methyl-N-nitro

88 normal neighbors on malignant progression of precancerous lesions is not well understood.

89 The precancerous lesion known as Barrett's oesophagus can ev

90 ationships among multiple oral cancerous and precancerous lesions (MOCP), we analysed 100 lesions fro

91 altered hepatic foci, which are the earliest precancerous lesions observed in the liver of woodchuck

92 al supplementation of green tea extract on a precancerous lesion of oral cavity.

93 Paradoxically, the precancerous lesions of EL-Kras/Tgfbr1(+/-) mice were co

94 scopy could risk-stratify patients harboring precancerous lesions of the colon, using an optically me

95 Thus, remarkably, features of precancerous lesions often attributed to defects in cell

96 elops through a stochastic mechanism whereby precancerous lesions on occasion progress to multifocal

97 sion procedure (LEEP) treatment for cervical precancerous lesions on subsequent acquisition of new hu

98 beta nonresponsive stromal cells resulted in precancerous lesions, only the mixture of TGF-beta respo

99 tumor (OR = 4.57, 95% CI: 2.25 to 9.30) and precancerous lesions (OR = 1.55, 95% CI: 1.06 to 2.27).

100 ns was significantly associated with gastric precancerous lesions (OR = 2.51, 1.13-5.56) among those

101 ed from 116 esophageal adenocarcinoma and 26 precancerous lesion patients using Affymetrix SNP 6.0 ar

102 NA methylation occurs within promoter before precancerous lesion plays a pivotal role that could help

103 Since precancerous lesions precede intestinal-type gastric can

104 In early precancerous lesions, S100PBP is translocated to the cyt

105 s do not develop many of the novel tumors or precancerous lesions seen in Rb+-;p53-- compound mutants

106 Detection of precancerous lesions such as CR adenoma is a key to redu

107 Our findings suggest that certain precancerous lesions, such as Barrett's, initiate not fr

108 IPMT is a dysplastic and likely precancerous lesion that is frequently diagnosed as chro

109 nomas in the large intestine, similar to the precancerous lesions that develop in patients with FAP.

110 ate carcinogenesis can develop a spectrum of precancerous lesions that resemble human prostatic intra

111 t cuSCC arise in association with a distinct precancerous lesion, the actinic keratosis (AK).

112 rocedures that can detect disease and remove precancerous lesions, there is a need for a model that e

113 event that can accelerate the transition of precancerous lesions to cancer.

114 It may be used to diagnose malignant or precancerous lesions, to delineate the margins for tumor

115 The frequency of precancerous lesions was 4-fold lower in haploinsufficie

116 The sensitivity for detecting advanced precancerous lesions was 42.4% with DNA testing and 23.8

117 d with diethylnitrosamine, the occurrence of precancerous lesions was enhanced compared with that in

118 non-significant odds ratio (OR) for gastric precancerous lesions was observed in relation to increas

119 The development of the precancerous lesions was significantly reversed by the a

120 Our previous works suggest that although precancerous lesions were found in Pten heterozygous mic

121 ssociated with esophageal adenocarcinoma and precancerous lesions, which implies that Bmi-1 plays an

122 of developing pancreatic cancer to identify precancerous lesions while they are amenable to cure.

123 shown to detect both colorectal cancers and precancerous lesions with high accuracy.

124 s with squamous cell T1a carcinoma, ten with precancerous lesions with hyperkeratosis, and ten subjec